News for Aldeyra Therapeutics, Inc. (ALDX)

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by c

We recently published a list of Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks. In this article, we are going to take a look at where Aldeyra Therapeutics, Inc.

SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by c

Discover the latest updates on Aldeyra Therapeutics and its potential for commercialization, with insights from industry analysts.

Investors need to pay close attention to Aldeyra Therapeutics (ALDX) stock based on the movements in the options market lately.

[url="]Aldeyra Therapeutics, Inc.[/url] (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed t

On November 14, 2024, Knoll Capital Management, LLC (Trades, Portfolio) executed a significant transaction by acquiring an additional 2,000,000 shares of Entera

Aldeyra (ALDX) announced FDA acceptance of its resubmitted market application for reproxalap and an expansion of its option agreement with AbbVie (ABBV). Read more here.

[url="]Aldeyra Therapeutics, Inc.[/url] (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the r

The exosome market is fueled by several significant factors, such as the rising incidence of chronic diseases, improvements in diagnostic methods, and...

Aldyera therapeutics director Nancy Miller-Rich buys $10,446 in stock

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are...

The increasing incidence of respiratory conditions like asthma, COPD, and bronchitis mainly drives the growth of the inhalable drugs market. Additionally,...

Discover unique investment opportunities in less-covered stocks like Kraken Robotics, Procter & Gamble, Fannie Mae, and Freddie Mac junior preferreds.

The week saw FDA reprimanding a pharma giant for making false and misleading claims about its non-small cell lung cancer drug and a developer of MDMA therapy for PTSD facing a major setback.

The dynamics of the atopic dermatitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies. The rising...

SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws...

The global pulmonary drugs market is projected to experience a steady CAGR between 2024 and 2030. This growth is mainly attributed to the increasing...

Infobird Co., Ltd (IFBD) is up over 80% in Tuesday's pre-market trading. The following are some of the other stocks making big moves..